Safe’n’Spray: Winner at CPhI Festival of Pharma

Nemera’s  concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'. This recognition was announced during the awards ceremony on 13 October 2020 on the digital platform of CPhI Festival of Pharma. Safe’n’Spray is...

Odin Vision receives NIHR funding to accelerate its AI technology for patient benefit

NIHR (National Institute for Health Research) has recognised Odin Vision as one of the companies to benefit from its new funding stream which accelerates the testing of cutting-edge AI technologies in the NHS. The AI...

UCLB spinout Freeline Closes $120 Million Series C Financing Round

Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced the closing of a $120 million extended Series C financing. The financing augments Syncona’s previously announced Series C investment in Freeline of $40 million (£30.6 million) with an additional...

New online tool pinpoints HIV health inequalities in England

The rate of late HIV diagnosis, which is associated with a tenfold increase in mortality, varies from 25% to 69% across England with black African heterosexual men being disproportionately likely to be diagnosed late*. A...

Work begins on UK system for estimating COVID-19 cases from wastewater

Scientists will develop a standardised UK-wide system for detecting coronavirus in wastewater, in order to provide an early warning of future outbreaks and reduce reliance on costly testing of large populations. The majority of people...

Rare tick-borne infections diagnosed

Public Health England has confirmed the diagnosis of a case of babesiosis and a probable case of tick-borne encephalitis in England. This is the first record of a UK-acquired case of babesiosis and the second...

New service tackles pulmonary disease

The introduction of a new service that could help thousands of people with chronic obstructive pulmonary disease manage their condition has been supported by UK Research and Innovation’s Digital Health Technology Catalysts. COPD affects approximately...

Goats get the point of human gestures

Goats can interpret human cues, such as the pointing gesture, to gather information about their environment, according to a new study Goats can interpret human cues, such as the pointing gesture, to gather information about...

Mycoplasma, the Trojan Horse of cell culture!

Sonia Houghton, CEO Cryoniss Mycoplasma are the smallest free-living organisms and considered to be the simplest form of bacteria, from the class Mollicutes. The presence of Mycoplasma in cell culture has been well established, ever since...

Axol Bioscience appoints Liam Taylor as Chief Executive Officer

New CEO to steer the next stage of Axol Bioscience’s growth in the global iPSC stem cell markets Cambridge, UK, 27 August 2020: Axol Bioscience, a biotechnology company specializing in the use of stem cell technology to...

Arctoris and Syntekabio Form Research Partnership

Arctoris, the creator of the world’s first fully automated drug discovery platform, has signed a Memorandum of Understanding with listed Korean company Syntekabio, Inc. to collaborate on drug discovery efforts. The first project under...

Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875

Next Generation ADC Uses Proprietary Technologies Aimed at Enhancing Cancer Therapy Efficacy and Safety Nijmegen, The Netherlands – 11 August 2020 – Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) today announced that the first cancer patients...

LAUDA Technology Ltd.

LAUDA is advancing the connectivity of temperature control technology with the new Integral process thermostats. Thanks to the modular interface concept and intuitive operation via the integrated web server, they are more user-friendly and...

UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S....

London, and New York, NY, 21 July 2020 – UCL Business (UCLB) and Apollo Therapeutics (Apollo), a pioneering collaboration between three global pharmaceutical companies and three UK university technology transfer offices, along with Deerfield Management Company,...

Opening new pathways for bioprocessing

A pivotal link between industry and academia, Teesside University’s £22m National Horizons Centre (NHC) opened last September with two very clear objectives. One is to drive research into bioprocessing, an often-overlooked subject through which life...

Firms call for major R&I investment to tackle environmental crises

Major investment into research and innovation (R&I) is needed to enable UK businesses to address the global biodiversity and climate crises, according to a new report. The report by the Valuing Nature Programme --– which...